Multiomics investigation of the female hypertensive human heart

Zachary J Milstone1, Jesse D Moreira-Bouchard1,2, Karan K Smith1

  • 1Evans Department of Medicine and The Whitaker Cardiovascular Institute, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.

Physiological Reports
|October 2, 2025
PubMed

Insights

Hypertension alters cardiac molecular pathways, including DNA repair and metabolism, and affects cell populations in adult hearts. This study provides crucial human data on the molecular signature of high blood pressure.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Human Pathology

Background:

  • Hypertension is a major risk factor for heart disease, affecting millions globally.
  • Existing knowledge relies heavily on animal models, lacking human cardiovascular tissue insights.
  • Previous work established a protocol for preserving postmortem human hearts for research.

Purpose of the Study:

  • To investigate the molecular changes in adult human hearts associated with hypertension.
  • To utilize multiomics analyses on postmortem cardiac tissue.
  • To establish a foundation for studying human cardiovascular disease.

Main Methods:

  • Pilot multiomics analyses (bulk RNA-seq, single-nucleus RNA-seq, metabolomics) on postmortem human hearts.
  • Comparison between hearts from donors with hypertension (n=3) and without (n=2).
  • Systematic dissection and preservation of whole human hearts.

Main Results:

  • Hypertension linked to increased transcripts for DNA helicase activity, NAD-dependent deacetylase activity, and branched-chain amino acid metabolism.
  • Single-nucleus RNA-seq revealed loss of contractile vascular smooth muscle cells and increased endothelial cell proliferation in hypertensive hearts.
  • Metabolomics indicated reductive stress and altered metabolic pathways, including fatty acid oxidation and the pentose phosphate pathway.

Conclusions:

  • Multiomics analysis of postmortem human hearts is a viable method for cardiovascular disease research.
  • Identified molecular signatures of hypertension in adult cardiac tissue, including cellular and metabolic alterations.
  • Provides novel human-based molecular insights into hypertension's cardiac impact.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.9K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
800
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
411